Evidence map›Paper›PMID 21999595›Full record

ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2011

mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury.

Charles H C Pilgrim, Kate Brettingham-Moore, Alan Pham, William Murray, Emma Link, Marty Smith, Val Usatoff, Peter M Evans, Simon Banting, Benjamin N Thomson and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Charles H C PilgrimDivision of Cancer Surgery, The Alfred Hospital Department of Pathology, The Alfred Hospital, Melbourne, Victoria, Australia. charlespilgrim@hotmail.com
Kate Brettingham-Moore
Alan Pham
William Murray
Emma Link
Marty Smith
Val Usatoff
Peter M Evans
Simon Banting
Benjamin N Thomson
Michael Michael
Wayne A Phillips
The Alfred Hospital · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChemotherapy-induced hepatic injuries (CIHI) are an increasing problem facing hepatic surgeons. It may be possible to predict the risk of developing CIHI by analysis of genes involved in the metabolism of chemotherapeutics, previously established as associated with other forms of toxicity.

methodsQuantitative reverse transcriptase-polymerase chain reaction methodology (q-RT-PCR) was employed to quantify mRNA expression of nucleotide excision repair genes ERCC1 and ERCC2, relevant in the neutralization of damage induced by oxaliplatin, and genes encoding enzymes relevant to 5-flurouracil metabolism, [thymidylate synthase (TS), thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD)] in 233 hepatic resection samples. mRNA expression was correlated with a histopathological injury scored via previously validated methods in relation to steatosis, steatohepatitis and sinusoidal obstruction syndrome.

resultsLow-level DPD mRNA expression was associated with steatosis [odds ratio (OR) = 3.95, 95% confidence interval (CI) = 1.53-10.19, P < 0.003], especially when stratified by just those patients exposed to chemotherapy (OR = 4.48, 95% CI = 1.31-15.30 P < 0.02). Low expression of ERCC2 was associated with sinusoidal injury (P < 0.001). There were no further associations between injury patterns and target genes investigated.

conclusionsPredisposition to the development of CIHI may be predictable based upon individual patient expression of genes encoding enzymes related to the metabolism of chemotherapeutics.

Indexed as

Antineoplastic AgentsChemical and Drug Induced Liver InjuryColorectal NeoplasmsDihydrouracil Dehydrogenase (NADP)DNA-Binding ProteinsEndonucleasesFatty LiverFluorouracilGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansLiverLiver NeoplasmsOdds RatioOrganoplatinum CompoundsOxaliplatinAntineoplastic AgentsDihydrouracil Dehydrogenase (NADP)DNA-Binding ProteinsEndonucleasesERCC1 protein, humanERCC2 protein, humanFluorouracilOrganoplatinum CompoundsOxaliplatinRNA, MessengerThymidine PhosphorylaseThymidylate SynthaseTYMP protein, humanXeroderma Pigmentosum Group D Protein

Identifiers

PMID21999595
PMCPMC3238016
OpenAlexW1992797711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.